Urine tenascinC is an independent risk factor for bladder cancer patients

By                    

Molecular Medicine Reports, Vol. 9, Iss. 3, 2014-01 ,pp. : 961-966

Spandidos Publications

Access to resources Recommend Favorite

Semi-quantitative analysis of telomerase activity of exfoliated cells in urine of patients with urothelial cancers: - A potential marker of bladder transitional cell carcinoma in bladder washes

By Akao T.   Kakehi Y.   Wu X.-X.   Kinoshita H.   Takahashi T.   Ogawa O.   Kato T.   Yoshida O.  

Urologic Oncology: Seminars and Original Investigations, Vol. 3, Iss. 4, 1997-07 ,pp. : 118-124

Elsevier

Access to resources Recommend Favorite

Diagnostic value of fibronectin and mutant p53 in the urine of patients with bladder cancer: impact on clinicopathological features and disease recurrence

By Eissa Sanaa  

Medical Oncology, Vol. 27, Iss. 4, 2010-12 ,pp. : 1286-1294

Humana Press, Inc

Access to resources Recommend Favorite

Matrix metalloproteinase-9 measured in urine from bladder cancer patients is an independent prognostic marker of poor survival

By Offersen Birgitte V.   Knap Marianne M.   Horsman Michael R.   Verheijen Jan   Hanemaaijer Roeland   Overgaard Jens  

Acta Oncologica, Vol. 49, Iss. 8, 2010-11 ,pp. : 1283-1287

Informa Healthcare

Access to resources Recommend Favorite

Altered surface expression patterns of circulating monocytes in cancer patients: impaired capacity of T-cell stimulation?

By Ugurel Selma   Lindemann Monika   Schadendorf Dirk   Grosse-Wilde Hans  

Cancer Immunology, Immunotherapy, Vol. 53, Iss. 11, 2004-11 ,pp. : 1051-1051

Springer Publishing Company

Access to resources Recommend Favorite